SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

They will have to be a reverse split

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
headshrink3 Member Profile
 
Followed By 2
Posts 98
Boards Moderated 0
Alias Born 04/24/13
160x600 placeholder
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 7/14/2017 5:18:33 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/26/2017 8:24:30 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/22/2017 11:50:31 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 6/22/2017 6:01:46 AM
RXi Pharmaceuticals Announces Completion of Enrollment of Phase 1/2 Clinical Trial with RXI-109 for Retinal Scarring "PR Newswire (US)" - 6/21/2017 7:05:00 AM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 6/16/2017 5:24:00 PM
RXi Pharmaceuticals Announces the Initiation of its Consumer Testing Program with RXI-231 "PR Newswire (US)" - 6/12/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/9/2017 5:22:12 PM
RXi Pharmaceuticals to Present at the Marcum MicroCap Conference "PR Newswire (US)" - 6/8/2017 7:05:00 AM
RXi Pharmaceuticals Corporation Announces the Appointment of Dr. Jonathan Freeman to its Board of Directors "PR Newswire (US)" - 6/7/2017 7:05:00 AM
RXi Pharmaceuticals to Present at the 3rd Annual Immuno-Oncology BD&L and Investment Forum "PR Newswire (US)" - 5/23/2017 7:05:00 AM
PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology "PR Newswire (US)" - 5/22/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/11/2017 7:16:49 AM
RXi Pharmaceuticals Reports First Quarter 2017 Financial Results and Recent Corporate Highlights "PR Newswire (US)" - 5/11/2017 7:05:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/11/2017 7:03:28 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 5/10/2017 6:01:10 AM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 5/4/2017 5:17:39 PM
RXi Pharmaceuticals to Webcast First Quarter 2017 Financial Results on Thursday, May 11, 2017 "PR Newswire (US)" - 5/4/2017 7:02:00 AM
RXi Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2017 Annual Meeting "PR Newswire (US)" - 5/2/2017 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/1/2017 7:17:12 AM
RXi Pharmaceuticals Corporation Selected to Present at the Cavendish Global Health Impact Forum "PR Newswire (US)" - 5/1/2017 7:02:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/27/2017 4:38:10 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/27/2017 4:33:56 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/26/2017 6:37:21 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 4/26/2017 6:29:11 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist